Clinical Data has announced positive results from a Phase III study of its investigative compound Vilazodone for the treatment of depression. According to the company, the primary and supportive secondary efficacy endpoints were met in the study.
From: www.pharmaceutical-business-review.com
Clinical Data sees positive results from pivotal depression drug trial
Posted by Ruslan Abuzant at 1:21 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment